A personalised medicine approach could soon be taken to non-small cell lung cancer (NSCLC), as researchers have discovered that patients' genomes determine their responses to certain treatments. Two studies, one conducted by East Asian researchers, one by a Spanish group, found that ...
Please Login to read the full article.
